Structure base drug discovery company
Amura Holdings Ltd., Minerva Building, Babraham Research Campus, Babraham, CB22 3AT, U.K.
Home
Company
Technologies
Programmes
Osteoporosis
Autoimmunity
Malaria
ß-lactamase inhibitors (BLIs)
Bone metastasis
Contact
Sitemap
Search
 
 
     
 

Programmes

The principle focus of the Amura programmes is the exploitation of the AMcore technology to address unmet therapeutic needs.

For more information on the Amura programmes, please use the sub-menus within the navigation pane on the left.

 

 
     
Email: amura@amura.co.uk
Phone: +44(0)1223 839797 Fax: +44(0)1223 839898 Copyright © 2008 Amura Holdings Ltd.